1	The	the	_	_	_	_	_	_	_
2	immediate-early	immediate-early	_	_	_	_	_	_	_
3	gene	gene	_	_	_	_	_	_	_
4	product	product	_	_	_	_	_	_	_
5	Egr-1	egr-1	_	_	_	_	_	_	_
6	regulates	regulate	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	interleukin-2	interleukin-2	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	beta-chain	beta-chain	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	through	through	_	_	_	_	_	_	_
14	noncanonical	noncanonical	_	_	_	_	_	_	_
15	Egr	Egr	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	Sp1	sp1	_	_	_	_	_	_	_
18	binding	binding	_	_	_	_	_	_	_
19	sites	site	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	interleukin-2	interleukin-2	_	_	_	_	_	_	_
3	IL-2	il-2	_	_	_	_	_	_	_
4	receptor	receptor	_	_	_	_	_	_	_
5	beta-chain	beta-chain	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	IL-2Rbeta	IL-2Rbeta	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	essential	essential	_	_	_	_	_	_	_
12	component	component	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	receptors	receptor	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	IL-2	il-2	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	IL-15	IL-15	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	IL-2Rbeta	IL-2Rbeta	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	constitutively	constitutively	_	_	_	_	_	_	_
5	expressed	express	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	its	its	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	can	can	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	further	further	_	_	_	_	_	_	_
14	induced	induce	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	number	number	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	stimuli	stimulus	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	including	include	_	_	_	_	_	_	_
22	phorbol	phorbol	_	_	_	_	_	_	_
23	12-myristate	12-myristate	_	_	_	_	_	_	_
24	13-acetate	13-acetate	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	PMA	PMA	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	now	now	_	_	_	_	_	_	_
4	characterized	characterize	_	_	_	_	_	_	_
5	factors	factor	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	bind	bind	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	enhancer	enhancer	_	_	_	_	_	_	_
11	region	region	_	_	_	_	_	_	_
12	located	located	_	_	_	_	_	_	_
13	between	between	_	_	_	_	_	_	_
14	nucleotides	nucleotide	_	_	_	_	_	_	_
15	-170	-170	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	-139	-139	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	human	human	_	_	_	_	_	_	_
21	IL-2Rbeta	IL-2Rbeta	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	Sp1	sp1	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	Sp3	sp3	_	_	_	_	_	_	_
5	bound	bind	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	5	5	_	_	_	_	_	_	_
9	’	'	_	_	_	_	_	_	_
10	portion	portion	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	this	this	_	_	_	_	_	_	_
13	region	region	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	whereas	whereas	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	PMA-inducible	pma-inducible	_	_	_	_	_	_	_
18	factor	factor	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	PIF	PIF	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	mainly	mainly	_	_	_	_	_	_	_
23	bound	bind	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	its	its	_	_	_	_	_	_	_
26	3	3	_	_	_	_	_	_	_
27	’	'	_	_	_	_	_	_	_
28	portion	portion	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	bound	bind	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	Sp	Sp	_	_	_	_	_	_	_
34	binding	binding	_	_	_	_	_	_	_
35	motifs	motif	_	_	_	_	_	_	_
36	as	as	_	_	_	_	_	_	_
37	well	well	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	Jurkat	Jurkat	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	induction	induction	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	PIF	PIF	_	_	_	_	_	_	_
9	DNA	DNA	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	activity	activity	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	rapidly	rapidly	_	_	_	_	_	_	_
14	induced	induce	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	required	require	_	_	_	_	_	_	_
17	de	de	_	_	_	_	_	_	_
18	novo	novo	_	_	_	_	_	_	_
19	protein	protein	_	_	_	_	_	_	_
20	synthesis	synthesis	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	sustained	sustained	_	_	_	_	_	_	_
25	at	at	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	high	high	_	_	_	_	_	_	_
28	level	level	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	at	at	_	_	_	_	_	_	_
31	least	least	_	_	_	_	_	_	_
32	23	23	_	_	_	_	_	_	_
33	h.	h.	_	_	_	_	_	_	_
34	Interestingly	interestingly	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	PIF	PIF	_	_	_	_	_	_	_
37	was	be	_	_	_	_	_	_	_
38	constitutively	constitutively	_	_	_	_	_	_	_
39	activated	activate	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	human	human	_	_	_	_	_	_	_
42	T-cell	t-cell	_	_	_	_	_	_	_
43	leukemia	leukemia	_	_	_	_	_	_	_
44	virus	virus	_	_	_	_	_	_	_
45	type	type	_	_	_	_	_	_	_
46	1-transformed	1-transformed	_	_	_	_	_	_	_
47	MT-2	mt-2	_	_	_	_	_	_	_
48	cells	cell	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	paper	paper	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	demonstrate	demonstrate	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	PIF	PIF	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	Egr-1	egr-1	_	_	_	_	_	_	_
11	based	base	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	its	its	_	_	_	_	_	_	_
14	recognition	recognition	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	anti-Egr-1	anti-egr-1	_	_	_	_	_	_	_
17	antisera	antiserum	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	gel	gel	_	_	_	_	_	_	_
20	mobility	mobility	_	_	_	_	_	_	_
21	shift	shift	_	_	_	_	_	_	_
22	assays	assay	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	even	even	_	_	_	_	_	_	_
25	though	though	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	IL-2Rbeta	IL-2Rbeta	_	_	_	_	_	_	_
28	DNA	DNA	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	motif	motif	_	_	_	_	_	_	_
31	differed	differ	_	_	_	_	_	_	_
32	substantially	substantially	_	_	_	_	_	_	_
33	from	from	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	canonical	canonical	_	_	_	_	_	_	_
36	Egr-1	egr-1	_	_	_	_	_	_	_
37	binding	binding	_	_	_	_	_	_	_
38	site	site	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	Egr-1	egr-1	_	_	_	_	_	_	_
5	bound	bind	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	Sp	Sp	_	_	_	_	_	_	_
9	binding	binding	_	_	_	_	_	_	_
10	site	site	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	Jurkat	Jurkat	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	both	both	_	_	_	_	_	_	_
6	sites	site	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	required	require	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	maximal	maximal	_	_	_	_	_	_	_
11	IL-2Rbeta	IL-2Rbeta	_	_	_	_	_	_	_
12	promoter	promoter	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	HeLaS3	helas3	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	transfection	transfection	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	Egr-1	Egr-1	_	_	_	_	_	_	_
23	could	could	_	_	_	_	_	_	_
24	drive	drive	_	_	_	_	_	_	_
25	activity	activity	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	reporter	reporter	_	_	_	_	_	_	_
29	construct	construct	_	_	_	_	_	_	_
30	containing	contain	_	_	_	_	_	_	_
31	both	both	_	_	_	_	_	_	_
32	sites	site	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	Sp1	Sp1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	Egr-1	Egr-1	_	_	_	_	_	_	_
6	could	could	_	_	_	_	_	_	_
7	form	form	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	complex	complex	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	kinetics	kinetic	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	correlated	correlate	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	production	production	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	Egr-1	egr-1	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	Jurkat	Jurkat	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	upon	upon	_	_	_	_	_	_	_
23	PMA	PMA	_	_	_	_	_	_	_
24	stimulation	stimulation	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	Sp1	Sp1	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	Egr-1	egr-1	_	_	_	_	_	_	_
6	physically	physically	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	functionally	functionally	_	_	_	_	_	_	_
9	cooperate	cooperate	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	mediate	mediate	_	_	_	_	_	_	_
12	maximal	maximal	_	_	_	_	_	_	_
13	IL-2Rbeta	IL-2Rbeta	_	_	_	_	_	_	_
14	promoter	promoter	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

